Pharmaceutical News

RSS

Taking "study drugs" can lead to other drug use and decline in mental health

Taking "study drugs" like Adderall without a diagnosis is not only dangerous in itself, but can lead to other drug use and a decline in mental health, according to new research from Binghamton University, State University of New York.

11 Mar 2024

Why covid patients who could most benefit from paxlovid still aren’t getting it

Evangelical minister Eddie Hyatt believes in the healing power of prayer but "also the medical approach." So on a February evening a week before scheduled prostate surgery, he had his sore throat checked out at an emergency room near his home in Grapevine, Texas.

11 Mar 2024

New research sheds light on how GLP-1 obesity drugs may change food cravings

GLP-1 analog treatments potentially alter food preferences and reduce obesity by decreasing appetite and food consumption, with further research needed for long-term weight maintenance using objective measures.

10 Mar 2024

Nirsevimab shows 90% success in shielding infants from RSV hospitalizations

Study demonstrated a 90% effectiveness of nirsevimab in preventing RSV-associated hospitalizations in infants, with a significant finding being the timely vaccination's role in offering protection.

10 Mar 2024

Man takes 217 COVID vaccines with no ill effects, shows immune boost

A case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.

7 Mar 2024

Reevaluating aspirin for heart attack and stroke prevention in seniors

One in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll shows.

7 Mar 2024

When it comes to ketamine, Meta’s posting policy is no party to decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential miracle drug for depression and other mental health conditions.

7 Mar 2024

Study provides insights into the action and specificity of splice-modifying drugs

Spinal muscular atrophy, or SMA, is the leading genetic cause of infant death. Less than a decade ago, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer showed this brutal disease can be treated by tweaking a process called RNA splicing.

6 Mar 2024

Study reveals mechanisms behind antidepressant effects of diabetes drug

Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression.

6 Mar 2024

From China to Uzbekistan - United for Women’s Wellness on IWD

On the occasion of International Women's Day (IWD), BGI Genomics interview Wang Leilei, a trailblazing blind model, and Viktoriya Tsay, an Uzbek advocate of women’s health. Their stories stich a cross-cultural narrative of nurturing the nuance of women’s wellness worldwide.

From BGI Genomics 6 Mar 2024

Biden is right. The US generally pays double that of other countries for Rx drugs.

It's well documented that Americans pay high prices for health care. But do they pay double or more for prescriptions compared with the rest of the world? President Joe Biden said they did.

6 Mar 2024

DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

Researchers from North Carolina State University have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids.

5 Mar 2024

RMIT-led study highlights the urgent need for more drug testing facilities in Australia

Testing of illicit drugs bought online found 35% were not what they said they were, highlighting the urgent need for more local drug testing facilities in Australia to prevent harm and overdose.

5 Mar 2024

Increased drug coverage restrictions in Medicare Part D raises concerns

Medicare Part D plans significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments, according to a new study from USC researchers.

4 Mar 2024

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

New research definitively shows that HIV antiretrovirals can be taken together with gender-affirming hormone therapy without changing how well either drug works.

4 Mar 2024

SolasCure publishes phase IIa clinical trial report in leading wound care journal

Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds.

From SolasCure 4 Mar 2024

How a friend’s death turned Colorado teens into anti-overdose activists

Gavinn McKinney loved Nike shoes, fireworks, and sushi. He was studying Potawatomi, one of the languages of his Native American heritage.

1 Mar 2024

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Researchers compare the extent of weight loss after one-year termination of active intervention with GLP-1 receptor agonist, exercise, or combination.

29 Feb 2024

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.

From BioCina Pty Ltd. 29 Feb 2024

Study: Many approved cancer drugs lack proof of added benefit

Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study published by The BMJ today.

28 Feb 2024

Previous
1
...
22
23
24
25
26
27
28
...
1433
Next

Pharmaceutical News

Taking "study drugs" can lead to other drug use and decline in mental health

Why covid patients who could most benefit from paxlovid still aren’t getting it

New research sheds light on how GLP-1 obesity drugs may change food cravings

Nirsevimab shows 90% success in shielding infants from RSV hospitalizations

Man takes 217 COVID vaccines with no ill effects, shows immune boost

Reevaluating aspirin for heart attack and stroke prevention in seniors

When it comes to ketamine, Meta’s posting policy is no party to decipher

Study provides insights into the action and specificity of splice-modifying drugs

Study reveals mechanisms behind antidepressant effects of diabetes drug

From China to Uzbekistan - United for Women’s Wellness on IWD

Biden is right. The US generally pays double that of other countries for Rx drugs.

DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

RMIT-led study highlights the urgent need for more drug testing facilities in Australia

Increased drug coverage restrictions in Medicare Part D raises concerns

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

SolasCure publishes phase IIa clinical trial report in leading wound care journal

How a friend’s death turned Colorado teens into anti-overdose activists

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

Study: Many approved cancer drugs lack proof of added benefit

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News